XML 38 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation Plans (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Stock Compensation Expense

The Company recorded the following Stock Compensation Expense in its consolidated statements of income (in thousands):

 

             
   Three Months ended  Nine Months ended
   September 30,  September 30,
   2021  2020  2021  2020
Stock option grants  $17    24    52    71 
Restricted stock awards   135    46    404    140 
Employee stock grant   —      —      50    530 
Annual director stock award               500    500 
Stock compensation    $152    70    1,006    1,241 
Summary of changes in outstanding options

A Summary of changes in outstanding options is presented below (in thousands, except share and per share amounts):

 

        Weighted   Weighted   Weighted
    Number   Average   Average   Average
    Of   Exercise   Remaining   Grant Date
Options   Shares   Price   Term (yrs)   Fair Value(000's)
                 
Outstanding at December 31, 2020     120,089     $ 35.33     5.3   $ 1,531  
    Exercised     (15,334   $ 17.54         $ (115 )
Outstanding at September 30, 2021     104,755     $ 37.93     5.1   $ 1,416  
                             
Exercisable at September 30, 2021     92,407     $ 36.87     4.8   $ 1,212  
                             

Vested during nine months ended

September 30, 2021

    —                   $ —    
Summary of changes in restricted stock awards

A Summary of changes in restricted stock awards is presented below (in thousands, except share and per share amounts):

        Weighted   Weighted   Weighted
    Number   Average   Average   Average
    Of   Exercise   Remaining   Grant Date
Restricted stock   Shares   Price   Term (yrs)   Fair Value(000's)
                 
Non-vested at December 31, 2020     20,520     $ 46.30     3.4   $ 950  
    Time-based awards granted     8,896       45.55           405  
    Performance-based awards granted     18,882       45.55           860  
Non-vested at September 30, 2021     48,298     $ 45.87     3.3   $ 2,215